When markets get choppy, many investors sit on the sidelines waiting for conditions to get better.
But long-term wealth is built by doing the opposite, buying high-quality stocks when uncertainty drags their share prices lower.
Right now, two ASX giants have been sold off heavily in 2025, despite continuing to strengthen their underlying businesses.
If I had $2,000 to put to work today, these ASX stocks would be at the top of my list.
CSL Ltd (ASX: CSL)
It is not often Australia’s biotech champion trades at this kind of discount. CSL shares are down sharply this year, falling close to 40% from their peak as investors react to slower margin recovery at CSL Behring, uncertainty around the planned spin-off of Seqirus, and noise surrounding potential US tariffs.
But despite this, the underlying fundamentals remain strong. CSL continues to benefit from rising global demand for plasma-derived therapies, with long-term demographic and healthcare trends firmly in its favour. Its pipeline is expanding, its US manufacturing investment is progressing, and the company remains one of the most profitable and resilient healthcare businesses in the world.
Importantly, CSL’s valuation has reset to levels not seen in a decade. At roughly 20x earnings, the stock is trading at a meaningful discount to its historical averages. Unsurprisingly, many major brokers now see significant upside, with price targets far above current levels.
For example, UBS has a buy rating and $275.00 price target on its shares, which implies potential upside of 50%.
WiseTech Global Ltd (ASX: WTC)
Another ASX stock that could be a great option for a $2,000 investment is WiseTech Global. It has also experienced a rare pullback in 2025, despite continuing to strengthen its position as one of the world’s most important logistics software companies.
Its CargoWise platform is embedded across global supply chains, used by many of the largest freight forwarders and logistics operators across Europe, Asia and North America.
The company’s recurring revenue model, sticky customer base, and history of disciplined acquisitions have made it one of the ASX’s most consistent tech performers over the past decade. And with global freight complexity increasing, WiseTech’s software is becoming more essential, not less.
Despite this, the share price has been volatile this year and that volatility offers an attractive entry point according to many brokers.
Morgans is one of them. It has a buy rating and $127.60 price target on the company’s shares.
The post My best ASX stocks to invest $2,000 in right now appeared first on The Motley Fool Australia.
Should you invest $1,000 in CSL right now?
Before you buy CSL shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 18 November 2025
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Bear market alert: ASX 200 tech shares down 24% since September peak
- Are CSL shares a buy amid the company’s $500 million cost-cutting plans?
- Buy, hold, sell: Sigma Healthcare, CSL, and Lynas shares
- Top 10 most-traded ASX shares last week
- Is the 2025 ASX share selloff your chance to buy generational bargains?
Motley Fool contributor James Mickleboro has positions in CSL and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply